Recent Finacing
Recent Raise
Nintx develops multi-target therapeutics from Brazilian biodiversity for microbiome-mediated multifactorial diseases, using xGI biomics (GI simulator) and GAIA path knowledge-graph platforms, advancing preclinical programs for licensing to pharma.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
